ERMEZA
Live / Registered — Registered (as of 28 Mar 2023)
What this means for you
Registered since 28 Mar 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88826046
- Registration number
- 7012836
- Mark type
- Stylized text
- Filed
- 09 Mar 2020
- Published for opposition
- 07 Jul 2020
- Registered
- 28 Mar 2023
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of thyroid disorders
Owner
- Mylan Pharmaceuticals, Inc., Morgantown, WV, US
- Mylan Pharmaceuticals, Inc., Morgantown, WV, US
- Mylan Pharmaceuticals, Inc., Morgantown, WV, US
Prosecution history
- 28 Mar 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 28 Mar 2023 — REGISTERED-PRINCIPAL REGISTER
- 22 Feb 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 21 Feb 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 22 Jan 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 20 Dec 2022 — USE AMENDMENT FILED
- 22 Jan 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 20 Dec 2022 — TEAS STATEMENT OF USE RECEIVED
- 02 Sept 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Aug 2022 — SOU EXTENSION 4 GRANTED
- 31 Aug 2022 — SOU EXTENSION 4 FILED
- 31 Aug 2022 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Feb 2022 — SOU EXTENSION 3 GRANTED
- 28 Feb 2022 — SOU EXTENSION 3 FILED